Analyst Research: Pfizer Inc (PFE)

PFE on New York Consolidated

34.16USD
26 Mar 2015
Change (% chg)

$-0.14 (-0.41%)
Prev Close
$34.30
Open
$34.11
Day's High
$34.40
Day's Low
$33.95
Volume
24,826,881
Avg. Vol
29,526,183
52-wk High
$35.45
52-wk Low
$27.51

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - PFIZER INC. (PFE-N) 5:50am EDT Thomson Reuters Stock Report 12 25.00
Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates. 2:31am EDT Stock Traders Daily 12 20.00
PFE: Due Diligence Review: Forensic Earnings and Valuation 25 Mar 2015 New Constructs, LLC 9 25.00
"The Economy Matters" Report for PFE: the economy's impact on PFE's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 23 Mar 2015 MacroRisk Analytics/EconomicInvestor 8 25.00
Wright Investors Service Comprehensive Report for Pfizer Inc. 22 Mar 2015 Wright Reports 57 75.00
ValuEngine Rating and Forecast Report for PFE 22 Mar 2015 ValuEngine, Inc. 11 25.00
ValuEngine Industry Report for Large CAP Pharma(PFE) 22 Mar 2015 ValuEngine, Inc. 10 49.00
Pfizer, Inc 21 Mar 2015 S&P Capital IQ – STARS Reports 11 127.00
PFIZER INC (PFE) - REPORT FOR ACTIVE TRADERS 20 Mar 2015 Pechala's Reports 1 25.00
TheStreet.com Ratings Stock Report For: PFIZER INC (PFE) 14 Mar 2015 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Ian Read

61 2011 Chairman of the Board, Chief Executive Officer

Frank D'Amelio

57 2010 Chief Financial Officer, Executive Vice President - Business Operations

Albert Bourla

53 2014 Group President - Vaccines, Oncology and Consumer Healthcare Business

Mikael Dolsten

56 2010 President - Worldwide Research and Development

Geno Germano

54 2014 Group President - Global Innovative Pharma Business
Search Stocks